HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C F Meares Selected Research

Lym-1 monoclonal antibody

9/2000Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C F Meares Research Topics

Disease

6Neoplasms (Cancer)
10/2001 - 04/2000
1Prostatic Neoplasms (Prostate Cancer)
09/2001
1Adenocarcinoma
04/2001
1Lymphoma (Lymphomas)
09/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2000
1Hematologic Neoplasms (Hematological Malignancy)
05/2000

Drug/Important Bio-Agent (IBA)

4Monoclonal AntibodiesIBA
09/2001 - 05/2000
2AntibodiesIBA
09/2001 - 09/2000
2Radioisotopes (Radionuclides)IBA
04/2001 - 04/2000
2Biological ProductsIBA
05/2000 - 04/2000
1Pharmaceutical PreparationsIBA
10/2001
1Immunoconjugates (Immunoconjugate)IBA
09/2001
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2001
1HaptensIBA
04/2001
1AcidsIBA
04/2001
1Iodine-131IBA
09/2000
1Copper-67IBA
09/2000
1Yttrium-90IBA
09/2000
1Lym-1 monoclonal antibodyIBA
09/2000
1AntigensIBA
09/2000

Therapy/Procedure

5Radioimmunotherapy
10/2001 - 05/2000
1Drug Therapy (Chemotherapy)
10/2001
1Intravenous Injections
04/2001
1Salvage Therapy
09/2000